BioMr. Bernardo is a veteran diagnostics executive who spent over 25 years with premier diagnostics organizations such as Thermo Fisher Scientific (NYSE: TMO), Siemens Healthcare, and Abbott Laboratories (NYSE: ABT). He took on the role of President of the Next-Generation Sequencing and Oncology division in 2015 and was responsible for leading Thermo Fisher’s efforts in these businesses, as well as his team which supp ....
Work Experience
Current
Past